Vimarsana
Biggest News Aggregation in the World

Synerfuse Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synerfuse Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synerfuse Inc Today - Breaking & Trending Today

SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study - Vimarsana News

SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse, Inc., a Minnesota-based medical device company, is pleased to announce that for the first time in the world,...

SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study - Vimarsana News

SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

--Study to Evaluate Safety and Tolerability of Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Lower Back Pain Patien...

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain - Vimarsana News

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

/PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept...

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain - Vimarsana News

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

/PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept...

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain - Vimarsana News

SynerFuse™ Announces Issuance of Key U.S. Patent on Novel Use of Neuromodulation for Treatment of Chronic Back Pain

MINNEAPOLIS, Feb. 15, 2022 /PRNewswire/ -- SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of ...